Caribou Biosciences's total assets for Q1 2026 were $149.00M, a decrease of -17.05% from the previous quarter. CRBU total liabilities were $46.98M for the fiscal quarter, a -18.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.